2,394
Views
22
CrossRef citations to date
0
Altmetric
Original Paper

Pharmacokinetics, biodistribution and receptor mediated endocytosis of a natural Angelica sinensis polysaccharide

, , , , , & show all
Pages 254-263 | Received 26 Sep 2017, Accepted 20 Dec 2017, Published online: 01 Jan 2018

Figures & data

Figure 1. Analysis of FA and ASP using HPGPC method.

Figure 1. Analysis of FA and ASP using HPGPC method.

Figure 2. Representative chromatograms for the determination of FA in plasma (A) and various tissues (B: liver; C: stomach; D: spleen; E: heart; F: intestines) by HPGPC. (1) Blank plasma or tissue; (2) Blank plasma or tissue spiked with standard FA solution; (3) Plasma or tissue samples collected after intravenous injection of FA; (4) FA dissolved in phosphate buffer (pH =7.4).

Figure 2. Representative chromatograms for the determination of FA in plasma (A) and various tissues (B: liver; C: stomach; D: spleen; E: heart; F: intestines) by HPGPC. (1) Blank plasma or tissue; (2) Blank plasma or tissue spiked with standard FA solution; (3) Plasma or tissue samples collected after intravenous injection of FA; (4) FA dissolved in phosphate buffer (pH =7.4).

Table 1. Calibration curves for FA in rat plasma and tissues (n = 5).

Table 2. Distribution of FA in tissues (n = 5)..

Figure 3. ASP concentration versus time profile following intravenous administration. Data are presented as mean ± SD (n = 6).

Figure 3. ASP concentration versus time profile following intravenous administration. Data are presented as mean ± SD (n = 6).

Figure 4. Hepatocytes uptake of FA. (A) Distributions of FA and FD in liver parenchymal and non-parenchymal cells 2 h after intravenous injection at a dose of 6 mg/kg. Values are given as mean ± SD (n = 3). (B) Fluorescence microscopic examination of paraffin sections of mice liver 2 h after intravenous injection of FA (B1) and FP (B2). The bar represents a length of 50 μm. (C) Fluorescence intensity of FA in liver parenchymal cells. (D) The uptake rate of FA in liver parenchymal cells. Values are given as mean ± SD (n = 3).

Figure 4. Hepatocytes uptake of FA. (A) Distributions of FA and FD in liver parenchymal and non-parenchymal cells 2 h after intravenous injection at a dose of 6 mg/kg. Values are given as mean ± SD (n = 3). (B) Fluorescence microscopic examination of paraffin sections of mice liver 2 h after intravenous injection of FA (B1) and FP (B2). The bar represents a length of 50 μm. (C) Fluorescence intensity of FA in liver parenchymal cells. (D) The uptake rate of FA in liver parenchymal cells. Values are given as mean ± SD (n = 3).

Figure 5. (A) Uptake rate of cells treated with different concentrations of FA (n = 3). ▪, HepG2 cells, •, Bel-7402 cells, ▲, Hela cells; (B) Effect of NGA on the uptake of FA to cells (n = 3); (C) Effect of NGA or dextran on the uptake of FA to mice liver (n = 3).

Figure 5. (A) Uptake rate of cells treated with different concentrations of FA (n = 3). ▪, HepG2 cells, •, Bel-7402 cells, ▲, Hela cells; (B) Effect of NGA on the uptake of FA to cells (n = 3); (C) Effect of NGA or dextran on the uptake of FA to mice liver (n = 3).

Figure 6. Preparation of 99mTc-DTPA-ASP. (A) The reaction route. (B) IR spectra of ASP and DTPA-ASP. (C) 1H-NMR spectra of ASP, DTPA and ASP-DTPA. (D) Chromatographic separation of 99mTc-DTPA-ASP and Na99mTcO4 using physiological as mobile phase.

Figure 6. Preparation of 99mTc-DTPA-ASP. (A) The reaction route. (B) IR spectra of ASP and DTPA-ASP. (C) 1H-NMR spectra of ASP, DTPA and ASP-DTPA. (D) Chromatographic separation of 99mTc-DTPA-ASP and Na99mTcO4 using physiological as mobile phase.

Figure 7. Planar images of rabbit after ear intravenous injection of 99mTc-DTPA-ASP with or without NGA. The upper row is control group; low row is blocking group.

Figure 7. Planar images of rabbit after ear intravenous injection of 99mTc-DTPA-ASP with or without NGA. The upper row is control group; low row is blocking group.
Supplemental material

Supplementary_material.docx

Download MS Word (3.3 MB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.